Chesnara PLC
LSE:CSN
Intrinsic Value
Chesnara Plc is a holding company, which engages in the provision of insurance solutions. [ Read More ]
The intrinsic value of one CSN stock under the Base Case scenario is 177.95 GBX. Compared to the current market price of 257 GBX, Chesnara PLC is Overvalued by 31%.
Valuation Backtest
Chesnara PLC
Run backtest to discover the historical profit from buying and selling CSN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Wall St
Price Targets
CSN Price Targets Summary
Chesnara PLC
According to Wall Street analysts, the average 1-year price target for CSN is 358.7 GBX with a low forecast of 303 GBX and a high forecast of 441 GBX.
Shareholder Return
CSN Price
Chesnara PLC
Average Annual Return | 0.69% |
Standard Deviation of Annual Returns | 8.71% |
Max Drawdown | -42% |
Market Capitalization | 386.8m GBX |
Shares Outstanding | 150 856 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Chesnara Plc is a holding company, which engages in the provision of insurance solutions. The company is headquartered in Preston, Lancashire and currently employs 322 full-time employees. The company went IPO on 2004-05-25. The Company’s segments include CA, Movestic, Waard Group and Scildon. The CA segment provides activities that are performed in the United Kingdom, where it underwrites life risks, such as those associated with death, disability and health and provides a portfolio of investment contracts for the savings and retirement needs of customers through asset management. The Movestic segment is focused on activities performed in Sweden, where it underwrites life, accident and health risks and provides a portfolio of investment contracts. The company is open to new business, securing distribution of its products principally through independent financial advisers. The Waard Group and Scildon segments represent the Company’s Dutch life and general insurance businesses.
Contact
IPO
Employees
Officers
The intrinsic value of one CSN stock under the Base Case scenario is 177.95 GBX.
Compared to the current market price of 257 GBX, Chesnara PLC is Overvalued by 31%.